首页> 外文OA文献 >Effect of Combination of Chinese Herbal Medicine versus Western Medicine on Mortality in Patients after Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
【2h】

Effect of Combination of Chinese Herbal Medicine versus Western Medicine on Mortality in Patients after Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

机译:中药对西医结合对心肺复苏后患者死亡率的影响:随机对照试验的系统综述与荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction. Although Chinese herbal medicine (CHM) treatment combined with conventional western therapy has been widely used and reported in many clinical trials in China, there is uncertainty about the efficacy of this combination in the treatment of patients after cardiopulmonary resuscitation (CPR). This systematic review aimed to assess whether the risk of mortality has decreased comparing the combination of CHM treatment with conventional western therapy. Methods. To identify relevant studies, the literature search was conducted in Medline, Embase, the Cochrane Library, CBM, CNKI, VIP, and Wanfang database. We included all randomized controlled trials (RCTs) that compared outcomes of patients after CPR taking combination of CHM treatment with those taking just conventional western therapy. Results. This meta-analysis showed that patients randomly assigned to combined CHM treatment group had a statistically significant 23% reduction in mortality compared with those randomly assigned to conventional western therapy group (RR: 0.77; 95% CI: 0.70–0.84). Conclusions. This meta-analysis provides evidence suggesting that a combined CHM therapy is associated with a decreased risk of mortality compared with conventional western therapy in patients after CPR. Further studies are needed to provide more evidence to prove or refute our conclusion and identify reasons for the reduction of mortality.
机译:介绍。虽然中草药(CHM)治疗与常规西方疗法相结合,但在中国的许多临床试验中得到了广泛应用和报道,但这种组合在心肺复苏后治疗患者的疗效存在不确定性,却存在不确定性(CPR)。这种系统审查旨在评估死亡率是否降低了与常规西方疗法的CHM治疗组合的比较。方法。为了确定相关研究,文献搜索是在Medline,Embase,Cochrane库,CBM,CNKI,VIP和WANFANG数据库中进行的。我们包括所有随机对照试验(RCT),在CPR后比较患者的结果,采取CHM治疗与常规西方疗法的那些组合。结果。该META分析表明,与随机分配给常规西方治疗组的那些(RR:0.77; 95%CI:0.70-0.84),患者随机分配给组合CHM治疗组的患者对死亡率的统计学显着显着显着显着降低了死亡率的23%。结论。该荟萃分析提供了证据表明,与CPR患者患者的常规西方治疗相比,联合的CHM治疗与死亡率的风险降低有关。需要进一步的研究来提供更多证据来证明或反驳我们的结论,并确定降低死亡率的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号